Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,481 | 57,990 | 53,167 | 53,371 | 55,629 |
| Receivables | 23,690 | 22,187 | 23,955 | 21,987 | 23,594 |
| Inventories | 18,787 | 16,284 | 16,922 | 21,336 | 23,809 |
| Other current assets | 0 | 0 | 0 | 0 | 5,126 |
| TOTAL | $103,358 | $101,590 | $99,317 | $102,509 | $113,652 |
| Non-Current Assets | |||||
| PPE Net | 40,324 | 40,684 | 41,083 | 40,461 | 38,994 |
| Intangibles | 9,704 | 9,701 | 9,717 | 9,704 | 9,615 |
| Other Non-Current Assets | 36,884 | 37,462 | 37,565 | 37,931 | 40,479 |
| TOTAL | $86,912 | $87,847 | $88,365 | $88,096 | $89,088 |
| Total Assets | $190,270 | $189,437 | $187,682 | $190,605 | $202,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,041 | 4,732 | 4,771 | 5,277 | 5,617 |
| Accrued Expenses | 15,867 | 14,357 | 11,310 | 12,624 | 13,567 |
| Other current liabilities | N/A | N/A | N/A | N/A | 4,122 |
| TOTAL | $21,908 | $19,089 | $16,081 | $17,901 | $23,306 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 24,897 | 23,543 | 23,929 | 24,307 | 25,445 |
| TOTAL | $24,897 | $23,543 | $23,929 | $24,307 | $25,445 |
| Total Liabilities | $46,805 | $42,632 | $40,010 | $42,208 | $48,751 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,401 | 14,421 | 14,418 | 14,341 | 14,176 |
| Common Shares | 139 | 144 | 144 | 143 | 144 |
| Retained earnings | 60,787 | 60,495 | 62,824 | 66,794 | 71,667 |
| Other shareholders' equity | -4,959 | -4,939 | -4,755 | -6,103 | -6,783 |
| TOTAL | $143,465 | $146,805 | $147,672 | $148,397 | $153,989 |
| Total Liabilities And Equity | $190,270 | $189,437 | $187,682 | $190,605 | $202,740 |